Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington University
Completed
Conditions studied: Sepsis, Adult Disease, Severe Sepsis, Emergency Department
In brief
The purpose of this study is to demonstrate that addition of the Monocyte Width Distribution (MDW) parameter to current standard of care improves a clinician's ability to recognize sepsis in the Emergency Department, resulting in earlier decision to administer antibiotics from time of ED presentation for sepsis patients (simulated primary endpoint), with concomitant reductions in length of stay and in-hospital mortality for those patients (secondary endpoints).
Key facts
- Study ID
- NCT04353388
- Run by
- Beckman Coulter, Inc.
- People needed
- 1139
- Starts
- 2020-02-03
- Expected to finish
- 2020-07-17
- Last updated by the study team
- 2021-03-17
Who can join
Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All race and ethnicities
- Presenting to the emergency department with suspicion of infection
- Whose assessment includes a CBC with differential
- Meets EMR Sepsis Definition
You may not qualify if…
- Pregnancy
- Prisoners
- Transfers from other ED
- Previously enrolled
Where it is running
- Washington University — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.